Welcome to Dividend.com
Please help us personalize your experience.
Select the one that best describes you
AMGN: NASDAQ (Stock)
Amgen
Dividend policy
Active
Price as of:
$253.09 +3.05 +1.22%
AMGN: NASDAQ (Stock)

Amgen

Dividend policy
Active
Price as of:
$253.09 +3.05 +1.22%
AMGN: NASDAQ (Stock)
Amgen
Dividend policy
Active
Price as of:
$253.09 +3.05 +1.22%
Watchlist
Dividend Data
Trading Data
Fwd Annualized Dividend / Yield
Dividend Yield is the relation between a stock’s Annualized Dividend and its current stock price. Click here to learn more.
Annualized Dividend is a standard in finance that lets you compare companies that have different payout frequencies. Click here to learn more. Forward implies that the calculation uses the next declared payout.
N/A / N/A
LTM Dividend / Yield
Dividend Yield is the relation between a stock’s Annualized Dividend and its current stock price. Click here to learn more.
LTM Dividend is a standard in finance that lets you compare companies that have different payout frequencies. LTM stands for “Last Twelve Months” and implies that the calculation uses the dividends paid over the last twelve months.
$5.80 / 2.33%
Fwd Payout Ratio
Fwd Payout Ratio is used to examine if a company’s earnings can support the current dividend payment amount. It divides the Forward Annualized Dividend by FY1 EPS. Click here to learn more.
N/A
Consecutive Yrs of Div Increase
Consecutive Years of Dividend Increase is the number of years in a row in which there has been at least one payout increase and no payout decreases.
1 yrs
Dividend Frequency
Quarterly
Healthcare Avg Trailing Yield
0.54%
Biotechnology Avg Trailing Yield
0.13%
Market Cap
$146.497 B
Day’s Range
$240.48 - $253.79
Volume
2,368,342
52 Wk Low/High
$173.12 - $264.97
Percent off 52 Wk High
-4.48%
FY1 PE
16.01x
FY1 EPS / Growth
$15.56 / 9.01%

Compare AMGN to Popular Dividend Stocks

Symbol Name Dividend.com Rating Fwd Yield Fwd Payout Ratio 3 Yr Avg Annual Dividend Growth Years of Consecutive Dividend Growth
locked_with_box locked_with_text 4.2 2.97% 59.12% 6.16% 8
locked_with_box locked_with_text 4.8 2.63% 51.34% 13.24% 10
locked_with_box locked_with_text 4.6 2.51% 51.61% 9.53% 9
locked_with_box locked_with_text 3.8 2.45% 83.21% 14.38% 56
locked_with_box locked_with_text 4.8 2.42% 53.81% 6.66% 10
Symbol Name Dividend.com Rating Fwd Yield Fwd Payout Ratio 3 Yr Avg Annual Dividend Growth Years of Consecutive Dividend Growth
Symbol Name Dividend.com Rating Fwd Yield Fwd Payout Ratio 3 Yr Avg Annual Dividend Growth Years of Consecutive Dividend Growth
Symbol Name Dividend.com Rating Fwd Yield Fwd Payout Ratio 3 Yr Avg Annual Dividend Growth Years of Consecutive Dividend Growth
Symbol Name Dividend.com Rating Fwd Yield Fwd Payout Ratio 3 Yr Avg Annual Dividend Growth Years of Consecutive Dividend Growth

Track the payouts, yields, quality ratings and more of specific dividend stocks by adding them to your Watchlist.

Symbol Name Dividend.com Rating Fwd Yield Fwd Payout Ratio 3 Yr Avg Annual Dividend Growth Years of Consecutive Dividend Growth

AMGN Payout Estimates

Estimated
Year Calendar Year Payout Calendar Year Payout Growth Pay Date Declared Date Ex-Dividend Date Payout Amount Qualified Dividend? Payout Type Frequency Days Taken For Stock Price To Recover
View Payout Estimates For The Next 12 Months

AMGN Payout History (Paid and Declared)

Declared
Paid
Year Calendar Year Payout Calendar Year Payout Growth Pay Date Declared Date Ex-Dividend Date Payout Amount Qualified Dividend? Payout Type Frequency Days Taken For Stock Price To Recover

AMGN Dividend Growth

Trade AMGN using the Dividend Capture Strategy


Is trading AMGN’s upcoming dividend a good idea?

Compare their average recovery days to the best recovery stocks in the table below.

Step 1

Find Stocks From the Table Below

Step 2

Buy the Stock One Day Before the Ex-Dividend Date

Step 3

Sell the Stock After it Recovers

How much you could have earned from trading AMGN’s dividend

$10,000
would earn you an annualized return of
Loading...
* Length of trade is estimated using the stock price recovery history.
* Annualized return assumes initial investment is continually reinvested in similar BDC stocks.

Best Dividend Capture Stocks

Symbol Name Dividend.com Rating Ex-Div Date Payout Amt Payout Type Payout Freq. Payout Increase? Dividend Capture Yield on Cost Dividend Capture Avg Days for Stock Price Recovery
locked_with_box locked_with_text locked_with_box 2020-07-17 $0.1750 Regular Quarterly locked_with_box 0.36% 0.7
locked_with_box locked_with_text locked_with_box 2020-07-22 $0.0300 Regular Semi Annually locked_with_box 0.01% 1.9
locked_with_box locked_with_text locked_with_box 2020-07-15 $0.3600 Regular Quarterly locked_with_box 0.48% 2.3
locked_with_box locked_with_text locked_with_box 2020-07-16 $0.6700 Regular Quarterly locked_with_box 0.34% 2.3
locked_with_box locked_with_text locked_with_box 2020-07-15 $0.1300 Regular Quarterly locked_with_box 0.13% 3.4
locked_with_box locked_with_text locked_with_box 2020-07-15 $1.7750 Regular Quarterly locked_with_box 0.96% 3.9

News & Research

News

Research

Company Profile

Company Overview

Exchanges: NASDAQ

Sector: Healthcare

Industry: Biotechnology

Additional Links:

Company Website

Investor Relations

Wiki Page

SEC Filings

Amgen (AMGN) - this company discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada. The company markets recombinant protein therapeutics in supportive cancer care, nephrology, and inflammation. Its principal products include Aranesp and EPOGEN erythropoietic-stimulating agents that stimulate the production of red blood cells; Neulasta and NEUPOGEN to stimulate the production of neutrophils, which is a type of white blood cell that helps the body to fight infections; and Enbrel, an inhibitor of tumor necrosis factor that plays a role in the body's response to inflammatory diseases. The company also markets other products comprising Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin (TPO) receptor agonist that mimics endogenous TPO, the primary driver of platelet production. In addition, it provides Denosumab, a human monoclonal antibody that targets RANKL, an essential regulator of osteoclasts. Further, the company offers product candidates in mid-to-late stage development in a variety of therapeutic areas, including oncology, hematology, inflammation, bone, nephrology, cardiovascular, and general medicine consisting of neurology. It markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and wholesale distributors of pharmaceutical products. The company has various collaborative arrangements with Pfizer Inc.; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Daiichi Sankyo Company, Limited; Array BioPharma Inc.; Kyowa Hakko Kirin Co. Ltd.; and Cytokinetics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

Related Companies

Company Name

Price

Change

% Change

Cempra, Inc.

$2.33

$0.03

1.304%

Cytori Therapeutics, Inc.

$0.21

-$0.01

-4.545%

Arsanis, Inc.

$3.11

-$0.12

-3.715%

PDL BioPharma Inc

$2.76

$0.05

1.845%

Hemispherx Biopharma, Inc.

$1.80

-$0.01

-0.552%

Melinta Therapeutics, Inc.

$0.44

-$0.06

-12.000%

Egalet Corporation

$0.03

-$0.06

-66.667%

© 2020&nbsp Market data provided is at least 15-minutes delayed and hosted by Barchart Solutions.

Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use, please see disclaimer